Novartis Ag (NVS) Free Cash Flow (2009 - 2026)
Novartis Ag recorded quarterly Free Cash Flow of $346.0 million in Q1 2026, down 43.19% quarter-over-quarter from $609.0 million in Q4 2025, and up 36.22% year-over-year from $254.0 million in Q1 2025.
Novartis Ag's Free Cash Flow history runs 18 years deep, the most recent figure standing at $346.0 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 36.22% year-over-year to $346.0 million; the TTM figure through Mar 2026 stood at $8.3 billion (down 38.07% YoY), while the FY2025 annual figure was $17.6 billion, up 8.26% from the prior year.
- Free Cash Flow came in at $346.0 million for Q1 2026 at Novartis Ag, down from $609.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $7.7 billion in Q4 2024 to a low of $168.0 million in Q1 2023.
- A 5-year average of $2.5 billion and a median of $354.0 million in 2025 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 36.22% in 2025 and fell as far as 92.09% in 2025.
- Novartis Ag's Free Cash Flow stood at $5.7 billion in 2022, then grew by 21.52% to $6.9 billion in 2023, then gained by 10.94% to $7.7 billion in 2024, then plunged by 92.09% to $609.0 million in 2025, then plunged by 43.19% to $346.0 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $346.0 million, $609.0 million, and $354.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 346.00 Mn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 3.01 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 1.47 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.56 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 2.93 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.48 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.43 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.18 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 757.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 346.00 Mn |
| Mar 31, 2026 | 346.00 Mn |
| Dec 31, 2025 | 609.00 Mn |
| Dec 31, 2025 | 609.00 Mn |
| Sep 30, 2025 | 354.00 Mn |
| Sep 30, 2025 | 354.00 Mn |
| Jun 30, 2025 | 7.00 Bn |
| Jun 30, 2025 | 7.00 Bn |
| Mar 31, 2025 | 254.00 Mn |
| Mar 31, 2025 | 254.00 Mn |
| Dec 31, 2024 | 7.70 Bn |
| Dec 31, 2024 | 7.70 Bn |
| Sep 30, 2024 | 321.00 Mn |
| Sep 30, 2024 | 321.00 Mn |
| Jun 30, 2024 | 5.14 Bn |
| Jun 30, 2024 | 5.14 Bn |
| Mar 31, 2024 | 227.00 Mn |
| Mar 31, 2024 | 227.00 Mn |
| Dec 31, 2023 | 6.94 Bn |
| Dec 31, 2023 | 6.94 Bn |
| Sep 30, 2023 | 261.00 Mn |
| Sep 30, 2023 | 261.00 Mn |
| Jun 30, 2023 | 3.80 Bn |
| Jun 30, 2023 | 3.80 Bn |
| Mar 31, 2023 | 168.00 Mn |
| Mar 31, 2023 | 168.00 Mn |
| Dec 31, 2022 | 5.71 Bn |
| Dec 31, 2022 | 5.71 Bn |
| Sep 30, 2022 | 221.00 Mn |
| Sep 30, 2022 | 221.00 Mn |
| Jun 30, 2022 | 4.01 Bn |
| Jun 30, 2022 | 4.01 Bn |
| Mar 31, 2022 | 257.00 Mn |
| Mar 31, 2022 | 257.00 Mn |
| Dec 31, 2021 | 6.72 Bn |
| Dec 31, 2021 | 6.72 Bn |
| Sep 30, 2021 | 351.00 Mn |
| Sep 30, 2021 | 351.00 Mn |
| Jun 30, 2021 | 4.45 Bn |
| Jun 30, 2021 | 4.45 Bn |
| Mar 31, 2021 | 246.00 Mn |
| Mar 31, 2021 | 246.00 Mn |
| Dec 31, 2020 | 7.01 Bn |
| Dec 31, 2020 | 7.01 Bn |
| Sep 30, 2020 | 279.00 Mn |
| Sep 30, 2020 | 279.00 Mn |
| Jun 30, 2020 | 4.20 Bn |
| Jun 30, 2020 | 4.20 Bn |
| Mar 31, 2020 | 237.00 Mn |
| Mar 31, 2020 | 237.00 Mn |
| Dec 31, 2019 | 461.00 Mn |
| Dec 31, 2019 | 461.00 Mn |
| Sep 30, 2019 | 357.00 Mn |
| Sep 30, 2019 | 357.00 Mn |
| Jun 30, 2019 | 3.39 Bn |
| Jun 30, 2019 | 3.39 Bn |
| Mar 31, 2019 | 282.00 Mn |
| Mar 31, 2019 | 282.00 Mn |
| Dec 31, 2018 | 444.00 Mn |
| Dec 31, 2018 | 444.00 Mn |
| Sep 30, 2018 | 295.00 Mn |
| Sep 30, 2018 | 295.00 Mn |
| Jun 30, 2018 | 4.20 Bn |
| Jun 30, 2018 | 4.20 Bn |
| Mar 31, 2018 | 258.00 Mn |
| Mar 31, 2018 | 258.00 Mn |
| Dec 31, 2017 | 638.00 Mn |
| Dec 31, 2017 | 638.00 Mn |
| Sep 30, 2017 | 382.00 Mn |
| Sep 30, 2017 | 382.00 Mn |
| Jun 30, 2017 | 3.91 Bn |
| Jun 30, 2017 | 3.91 Bn |
| Mar 31, 2017 | 344.00 Mn |
| Mar 31, 2017 | 344.00 Mn |
| Dec 31, 2016 | 586.00 Mn |
| Dec 31, 2016 | 586.00 Mn |
| Sep 30, 2016 | 443.00 Mn |
| Sep 30, 2016 | 443.00 Mn |
| Jun 30, 2016 | 448.00 Mn |
| Jun 30, 2016 | 448.00 Mn |
| Mar 31, 2016 | 385.00 Mn |
| Mar 31, 2016 | 385.00 Mn |
| Dec 31, 2015 | 753.00 Mn |
| Dec 31, 2015 | 753.00 Mn |
| Sep 30, 2015 | 579.00 Mn |
| Sep 30, 2015 | 579.00 Mn |
| Jun 30, 2015 | 566.00 |
| Jun 30, 2015 | 566.00 |
| Mar 31, 2015 | 469.00 |
| Mar 31, 2015 | 469.00 |
| Dec 31, 2014 | 830.00 |
| Dec 31, 2014 | 830.00 |
| Sep 30, 2014 | 668.00 |
| Sep 30, 2014 | 668.00 |
| Jun 30, 2014 | 644.00 |
| Jun 30, 2014 | 644.00 |
| Mar 31, 2014 | 482.00 |
| Mar 31, 2014 | 482.00 |
| Sep 30, 2013 | 759.00 |
| Sep 30, 2013 | 759.00 |
| Jun 30, 2013 | 633.00 |
| Jun 30, 2013 | 633.00 |
| Mar 31, 2013 | 497.00 |
| Mar 31, 2013 | 497.00 |
| Sep 30, 2012 | 662.00 |
| Sep 30, 2012 | 662.00 |
| Jun 30, 2012 | 604.00 |
| Jun 30, 2012 | 604.00 |
| Mar 31, 2012 | 412.00 |
| Mar 31, 2012 | 412.00 |
| Dec 31, 2011 | 785.00 |
| Dec 31, 2011 | 785.00 |
| Sep 30, 2011 | 510.00 |
| Sep 30, 2011 | 510.00 |
| Jun 30, 2011 | 453.00 |
| Jun 30, 2011 | 453.00 |
| Mar 31, 2011 | 419.00 |
| Mar 31, 2011 | 419.00 |
| Dec 31, 2010 | 673.00 |
| Dec 31, 2010 | 673.00 |
| Sep 30, 2010 | 346.00 |
| Sep 30, 2010 | 346.00 |
| Jun 30, 2010 | 355.00 |
| Jun 30, 2010 | 355.00 |
| Mar 31, 2010 | 3,611.00 |
| Mar 31, 2010 | 3,611.00 |
| Dec 31, 2009 | 12.19 Bn |
| Dec 31, 2009 | 12.19 Bn |
| Sep 30, 2009 | 3,569.00 |
| Sep 30, 2009 | 3,569.00 |
| Jun 30, 2009 | 3,103.00 |
| Jun 30, 2009 | 3,103.00 |
| Mar 31, 2009 | 2,321.00 |
| Mar 31, 2009 | 2,321.00 |